10-Q Filing

XILIO THERAPEUTICS, INC. CIK: 1840233 Q1 2023

Filing Information

Form Type	10-Q
Accession Number	`0001558370-23-008676`
Period End Date	20230331
Filing Date	20230509
Fiscal Year	2023
Fiscal Period	Q1
XBRL Instance	xlo-20230331x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 69 Income Statement 24 Cash Flow Statement 52 Stockholders Equity 14

Balance Sheet 69 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$120.39M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$176.96M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$93.27M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.71M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.11M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$96.98M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$124.50M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$1.57M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$1.56M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.47M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$7.25M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$7.25M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.47M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.43M	shares	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$5.48M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.44M	shares	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$5.58M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$232.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$267.00K	USD	Point-in-time
Total assets	`Assets`	$139.16M	USD	Point-in-time
Total assets	`Assets`	$111.50M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.01M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.12M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$10.33M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$6.48M	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$949.00K	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$918.00K	USD	Point-in-time
Note payable, current portion	`NotesPayableCurrent`	$6.67M	USD	Point-in-time
Note payable, current portion	`NotesPayableCurrent`	$6.67M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$82.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$82.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$21.12M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$16.19M	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	$3.17M	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	$1.55M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$9.19M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$8.95M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$26.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$45.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$26.71M	USD	Point-in-time
Total liabilities	`Liabilities`	$33.52M	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 5,000,000 shares authorized, no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 5,000,000 shares authorized, no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized at March 31, 2023 and December 31, 2022; 27,470,534 shares issued and 27,439,820 shares outstanding at March 31, 2023; 27,471,607 shares issued and 27,425,447 shares outstanding at December 31, 2022	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized at March 31, 2023 and December 31, 2022; 27,470,534 shares issued and 27,439,820 shares outstanding at March 31, 2023; 27,471,607 shares issued and 27,425,447 shares outstanding at December 31, 2022	`CommonStockValue`	$3.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$356.54M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$354.75M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-271.75M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-249.11M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$166.12M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$105.65M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$185.43M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$84.79M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$111.50M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$139.16M	USD	Point-in-time

Income Statement 24 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$14.92M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$16.13M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$7.39M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$6.30M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$21.22M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$23.53M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-21.22M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-23.53M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-129.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$880.00K	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$880.00K	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$-129.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.65M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.35M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-22.65M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-21.35M	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.78	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.83	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.78	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.83	USD	1 Quarter
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	27.37M	shares	1 Quarter
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	27.43M	shares	1 Quarter
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	27.37M	shares	1 Quarter
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	27.43M	shares	1 Quarter

Cash Flow Statement 52 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-22.65M	USD	1 Quarter
Net loss	`ProfitLoss`	$-21.35M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$499.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$440.00K	USD	1 Quarter
Non-cash interest expense	`NoncashInterestExpense`	$53.00K	USD	1 Quarter
Non-cash interest expense	`NoncashInterestExpense`	$31.00K	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$1.79M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$2.03M	USD	1 Quarter
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-406.00K	USD	1 Quarter
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-336.00K	USD	1 Quarter
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-108.00K	USD	1 Quarter
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-92.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-820.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.36M	USD	1 Quarter
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-3.87M	USD	1 Quarter
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-1.43M	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-185.00K	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-213.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-20.84M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-25.25M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$254.00K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$170.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-254.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-170.00K	USD	1 Quarter
Repayments of debt principal	`RepaymentsOfDebt`	$1.67M	USD	1 Quarter
Payments of finance lease	`FinanceLeasePrincipalPayments`	$21.00K	USD	1 Quarter
Payments of finance lease	`FinanceLeasePrincipalPayments`	$21.00K	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$16.00K	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.69M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-5.00K	USD	1 Quarter
Decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-27.11M	USD	1 Quarter
Decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-21.09M	USD	1 Quarter
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$178.51M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$94.84M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$199.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$94.84M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$199.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$178.51M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.95M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$209.00K	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	$119.00K	USD	1 Quarter
Capital expenditures included in accounts payable or accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$310.00K	USD	1 Quarter
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$120.39M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$176.96M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$93.27M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$1.57M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$1.55M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$94.84M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$178.51M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$121.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$199.61M	USD	Point-in-time

Stockholders Equity 14 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$166.12M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$105.65M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$185.43M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$84.79M	USD	Point-in-time
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$16.00K	USD	1 Quarter
Exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	156.00	shares	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.03M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.79M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.65M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.35M	USD	1 Quarter
Ending balance	`StockholdersEquity`	$166.12M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$105.65M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$185.43M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$84.79M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.